Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
10
10 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- TNG462Phase 23 trials
Tango Therapeutics, Inc. · MTAP-deleted Solid Tumors, Locally Advanced Solid Tumor, PDAC
- RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials
Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)
- S095029Phase 22 trials
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer
- BN104Phase 21 trial
Institut de Recherches Internationales Servier (I.R.I.S.) · ALL, Adult, AML, Adult, Acute Leukaemia
- S095018Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095024Phase 21 trial
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)
- S095035Phase 21 trial
Servier Bio-Innovation LLC · MTAP-deleted Solid Tumors
- S241656Phase 21 trial
Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia
- S243249Phase 21 trial
Servier · Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Myeloid Leukemia
- S247240Phase 21 trial
Institut de Recherches Internationales Servier (I.R.I.S.) · Fragile X Syndrome (FXS)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.